RUO Peptide Website Compliance Center
The PeptideShopify Compliance Center helps research-commerce merchants organize intended-use education, drafts of site policies and an initial claims preflight. It is a workflow for identifying issues and preparing specialist review—not an exemption from pharmaceutical regulation.
Start your free storefront draft ↗Understand how intended use is evaluated
The words “research use only” do not automatically determine regulatory status. Product presentation, descriptions, marketing, social posts, administration instructions and other evidence may indicate an intended human or veterinary use even when a research disclaimer appears nearby.
The education library addresses research-product claims, evidence of intended use, marketing communications, recordkeeping and responsibilities. Merchants should evaluate product-specific status under applicable laws with qualified counsel.
- Learn the difference between a research notice and actual intended-use evidence
- Avoid treatment, dosing or human administration marketing claims
- Keep claims and testimonials consistent across every channel
Review draft policies before publishing
The platform can generate clearly marked draft research-use notices, terms, privacy notices and shipping/returns pages. These are templates, not legal advice or signed contracts. A business must supply accurate merchant details, operating jurisdictions and privacy practices and obtain qualified review where needed.
A launch checklist distinguishes draft completion from counsel approval, payment underwriting and operational readiness. A document can be present without being legally adequate; the system deliberately does not turn “template generated” into “compliance certified.”
- Research-use information page
- Terms of sale draft
- Privacy practices and data-processing inventory
- Shipping, support and returns draft
Check product copy and campaigns
The content preflight scans merchant-supplied copy for phrases associated with disease treatment, dosing or administration, performance claims and unsupported assurances. Flagged examples are shown for revision; a clean keyword scan does not prove that a sales page is lawful.
Health-related advertising is evaluated by overall impression, not only literal phrases. Promotional text, links, imagery, affiliates and product context may need a human review before publication.
- Scan research catalog descriptions
- Review email and SMS drafts
- Escalate questionable claims for qualified human review
Official intended-use and advertising references
For authoritative definitions and current guidance, review the FDA's intended-use regulation (21 CFR 201.128) and the FTC Health Products Compliance Guidance. These references explain why the overall claims and intended uses of a product matter, rather than a disclaimer alone. A qualified professional should review how the rules apply to specific products and jurisdictions.
Common questions
Does an RUO disclaimer make every peptide lawful to sell?
No. Regulators consider objective intended use and the complete sales and marketing context. A disclaimer does not negate contradictory human-use claims.
Are the legal pages attorney approved?
No. The generated policies are clearly labeled drafts that require accurate merchant facts and qualified review.
Does the content scanner provide FDA approval?
No. The scanner is an advisory text preflight; it does not authorize any product or replace counsel.
Is the Compliance Center included in the free builder?
The introductory education and policy-draft workflow are part of the merchant setup. Other services can have separate eligibility and charges.
For lawful laboratory research commerce. No human or animal use, product authorization, legal certification or payment approval is implied.